top ten

As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …

October is almost over and Halloween is just around the corner, and it’s time for another run-down of the stories …

Another week gone, and it’s deadline day here at Pharmafocus, meaning you can look forward to our November issue next …

It’s been another packed week in the industry, with one of the biggest takeaways being that childhood obesity has rocketed …

It’s Friday, and it’s time for another round up of the most popular articles on pharmafile.com over the last seven …

It’s been a great week for drug research and access, with the first-ever FDA approval of a biosimilar in cancer …

This week has been a particularly eventful one for the industry: among our top stories, Martin Shkreli finally heads to …

This week saw a number of hard-hitting stories hit the headlines that are sure to have resonant consequences. Following the …

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …

As much as it might try, the pharmaceutical industry just isn’t able to keep the drug pricing debate out of …

A lot has happened in the world this week, but the pharma industry still found itself on the frontlines of …

Another week, another busy week in pharma. The last seven days have seen some remarkable strides in the diabetes space, …

Another week passes by, and the headlines have seen some shocking stories, such as the news that the UK is …

The week was characterised by two big psoriasis approval stories, while Amgen’s osteoporosis treatment was knocked back. Novartis CEO Joe …

As the week comes to a close, we bring you the stories that were most read by our readers – …